Transformation disruptive player in medical industry
10 years or more. That is how long it can take for a drug to be approved. Often doctors and their patients do not have access to the drug in the period before approval, while it may already be showing promising results. MyTomorrows wants to prevent patients from missing out on treatment options due to a lack of information and understanding, or administrative barriers. That is why they are committed to improving access to medicines in development.
The transformation of MyTomorrows
MyTomorrows is a disruptive organisation in the medical industry and is committed to improving access to medicines in development. This requires a transformation. Second Company supports this by developing a business portal.
The approach of Second Company
Second Company built a business portal for MyTomorrows. In the medical industry, data security is of course crucial. Security was therefore one of the most important points of attention during the construction of this portal.
The result
- Better and early access to medicines under development via the company portal.
